Arlington Capital invests in injectable drugs maker Afton Scientific
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward.
30 January 2024•1 min read
Tom Thorpe, founder and CEO of Afton, will continue to lead the company and remain a material shareholder going forward.
Speyside Equity buys Midwest steel tubing and building products maker Tapco
16 hours ago · 2 mins read
BayPine-backed Relation Insurance buys assets of St. Louis’s Wright Insurance Planning
16 hours ago · 1 min read
Baird Capital’s Blue Matter announces acquisition of London healthcare communications agency Cognite
16 hours ago · 1 min read
Strategic Value Partners agrees to back NewEdge Power in battery storage JV
17 hours ago · 2 mins read
Oak Hill strikes deal to take majority stake in Wyyerd from Carlyle
18 hours ago · 2 mins read
Polaris Growth Fund backs commercial real estate software firm ID Plans
18 hours ago · 1 min read
Third Space Partners buys live event drape and scenic provider Quest Events
19 hours ago · 2 mins read
